Immunogenicity of the drug "Live intranasal vaccine for the prevention of pertussis" (GamLPV) with a single use in healthy volunteers

Immunogenicity of the drug "Live intranasal vaccine for the prevention of pertussis" (GamLPV) with a single use in healthy volunteers

Introduction. A significant increase in the incidence of pertussis in the world, including among adolescents and adults, the prevalence of mild forms of the disease and asymptomatic carrier of bacteria B. pertussis, and the resulting need for mass revaccination of different age groups determine the...

Full description

Bibliographic Details
Main Authors: A. Yu. Medkova, A. A. Lidzhiyeva, E. G. Semin, L. N. Sinyashina, R. A. Syundyukova, N. A. Snegireva, I. N. Chernyshova, M. V. Gavrilova, K. K. Bushkova, L. V. Kolobukhina, I. S. Kruzhkova, L. N. Merkulova, M. G. Rusanova, I. N. Dyakov, G. I. Karatayev
Format: Article
Language:Russian
Published: Central Research Institute for Epidemiology 2022-01-01
Series:Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:
live attenuated vaccine
pertussis
bordetella pertussis
intranasal vaccination
humoral response
cellular response
mucosal response
immunogenicity
Online Access:https://microbiol.elpub.ru/jour/article/view/1149

Similar Items

Similar Items